Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Prevention of Post-Pericardiotomy Syndrome and AF
NCT02177266Phase 3Terminated
- Sponsor
- Mayo Clinic
- Start
- May 2015
- Primary completion
- Nov 2016
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in postpericardiotomy syndrome (PPS), Atrial fibrillation (AFib), constrictive pericarditis (CP), sponsored by Mayo Clinic. Started May 2015; status: terminated.
02
Drugs
colchicine
03
Conditions
postpericardiotomy syndrome (PPS)Atrial fibrillation (AFib)constrictive pericarditis (CP)
Beyond the preview
Go deeper on NCT02177266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177266.